The Stakes in Niche Therapeutics Niche therapeutics represent a rapidly growing segment of U.S. pharmaceutical sales. … AI-Enhanced Sales Forecasting for Niche Therapeutics: Transforming U.S. Pharma Strategy in 2025Read more
FDA
FDA’s Crackdown on Pharma’s Digital Marketing: What the Warning Letters to Lilly, Novo, and Novartis Signal for the Future of DTC Advertising
For years, pharmaceutical marketing teams have operated in a gray zone—especially on social media. Branded content, … FDA’s Crackdown on Pharma’s Digital Marketing: What the Warning Letters to Lilly, Novo, and Novartis Signal for the Future of DTC AdvertisingRead more
Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma Marketing
The glossy world of pharmaceutical advertising is facing its biggest regulatory reset in two decades. For … Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma MarketingRead more
FDA Expands Crackdown on Deceptive DTC Ads with New Rulemaking: Closing the 1997 Loophole and Redefining Pharma Marketing
The pharmaceutical industry has long relied on glossy direct-to-consumer (DTC) ads to shape patient behavior. From … FDA Expands Crackdown on Deceptive DTC Ads with New Rulemaking: Closing the 1997 Loophole and Redefining Pharma MarketingRead more